Aggrey Bukuru Selected Research

Fluconazole (Zonal)

1/2023

Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aggrey Bukuru Research Topics

Disease

3	Acquired Immunodeficiency Syndrome (AIDS) 10/2023 - 01/2018
2	Kaposi Sarcoma (Kaposi's Sarcoma) 10/2023 - 01/2018
1	Inflammation (Inflammations) 10/2023
1	Cryptococcal Meningitis 01/2023

Drug/Important Bio-Agent (IBA)

2	Etoposide (VP 16)FDA LinkGeneric 10/2023 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 10/2023
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2023
1	C-Reactive ProteinIBA 10/2023
1	Interferon-gamma (Interferon, gamma)IBA 10/2023
1	InterleukinsIBA 10/2023
1	LigandsIBA 10/2023
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023
1	EndoglinIBA 10/2023
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2023
1	ChemokinesIBA 10/2023
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2023
1	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2023
1	Fluconazole (Zonal)FDA LinkGeneric 01/2023

Therapy/Procedure

2	Therapeutics 10/2023 - 01/2018
2	Art Therapy 10/2023 - 01/2018
2	Drug Therapy (Chemotherapy) 10/2023 - 01/2018